home / stock / cytr / cytr quote
Last: | $ |
---|---|
Change Percent: | -5.08% |
Open: | $0.295 |
Close: | $0.28 |
High: | $0.299 |
Low: | $0.268 |
Volume: | 18,540 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.295 | $0.28 | $0.299 | $0.268 | 18,540 | 10-17-2019 |
$ | $0.275 | $0.295 | $0.295 | $0.2675 | 2,052 | 10-16-2019 |
$ | $0.2641 | $0.295 | $0.295 | $0.2641 | 19,616 | 10-15-2019 |
$ | $0.28055 | $0.28 | $0.282 | $0.2641 | 7,524 | 10-14-2019 |
$ | $0.29995 | $0.291 | $0.29995 | $0.282 | 26,048 | 10-11-2019 |
$ | $0.299 | $0.30 | $0.30 | $0.2815 | 14,954 | 10-10-2019 |
$ | $0.275 | $0.29 | $0.30 | $0.27 | 2,886 | 10-09-2019 |
$ | $0.28 | $0.30 | $0.30 | $0.27 | 17,444 | 10-08-2019 |
$ | $0.28 | $0.30 | $0.3189 | $0.28 | 81,480 | 10-07-2019 |
$ | $0.3189 | $0.317 | $0.3189 | $0.28 | 15,182 | 10-04-2019 |
$ | $0.32 | $0.3189 | $0.33 | $0.2905 | 23,940 | 10-03-2019 |
$ | $0.32 | $0.32 | $0.32 | $0.27 | 40,471 | 10-02-2019 |
$ | $0.2865 | $0.32 | $0.33 | $0.279 | 19,761 | 10-01-2019 |
$ | $0.29255 | $0.325 | $0.325 | $0.29 | 9,140 | 09-30-2019 |
$ | $0.325 | $0.325 | $0.325 | $0.2901 | 13,123 | 09-27-2019 |
$ | $0.3125 | $0.3125 | $0.3125 | $0.3125 | 398 | 09-26-2019 |
$ | $0.305 | $0.325 | $0.33 | $0.2901 | 78,042 | 09-25-2019 |
$ | $0.33 | $0.305 | $0.33 | $0.30 | 26,125 | 09-24-2019 |
$ | $0.312 | $0.30 | $0.321 | $0.30 | 15,005 | 09-23-2019 |
$ | $0.312 | $0.312 | $0.33 | $0.312 | 23,953 | 09-20-2019 |
News, Short Squeeze, Breakout and More Instantly...
LadRx Corporation (OTCQB: LADX) (“LadRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced it is changing its OTCQB ticker symbol from CYTR to LADX effective Thursday, Octo...
The New LadRx Corporation Name Will Be Effective on September 26, 2022 and Will Continue to Trade Under the Ticker CYTR until the new symbol has been approved by FINRA CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceut...
Patent Protects the LADR Platform and Drugs Employing LADR CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced it has...